Dibenzo-azepine derivatives as .alpha.v integrin receptor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 515/12 (2006.01) A61K 31/551 (2006.01) A61K 31/553 (2006.01) A61K 31/554 (2006.01) A61P 9/10 (2006.01) A61P 19/08 (2006.01) C07D 223/18 (2006.01) C07D 243/10 (2006.01) C07D 243/38 (2006.01) C07D 267/12 (2006.01) C07D 267/20 (2006.01) C07D 273/06 (2006.01) C07D 281/02 (2006.01) C07D 285/36 (2006.01) C07D 291/08 (2006.01) C07D 471/02 (2006.01) C07D 471/12 (2006.01) C07D 487/02 (2006.01) C07D 487/12 (2006.01) C07D 498/02 (2006.01) C07D 498/12 (2006.01) C07D 513/02 (2006.01) C07D 513/12 (2006.01) C07D 515/

Patent

CA 2362334

The present invention relates to dibenzo-azepine derivatives and their use as alphaV integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alphaVbeta3, alphaVbeta5, and/or alphaVbeta6 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, wound healing, viral disease, tumor growth, and metastasis.

Cette invention concerne des dérivés de la dibenzo-azépine et leur utilisation comme antagonistes du récepteur d'alphaV integrine. Plus particulièrement, les composés selon la présente invention sont des antagonistes des récepteurs de l'intégrine alphaVbeta3, alphaVbeta5, et/ou alphaVbeta6. Ils servent à inhiber la résorption osseuse, à traiter et à prévenir l'ostéoporose, à favoriser la cicatrisation des blessures, à inhiber la resténose vasculaire, la rétinophatie diabétique, la dégénérescence maculaire, l'angiogenèse, l'athérosclérose, les inflammations, les maladies virales ainsi que la croissance des tumeurs et des métastases.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dibenzo-azepine derivatives as .alpha.v integrin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dibenzo-azepine derivatives as .alpha.v integrin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenzo-azepine derivatives as .alpha.v integrin receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1585085

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.